167 related articles for article (PubMed ID: 3117118)
21. Complete inhibition of human immunodeficiency virus Gag myristoylation is necessary for inhibition of particle budding.
Morikawa Y; Hinata S; Tomoda H; Goto T; Nakai M; Aizawa C; Tanaka H; Omura S
J Biol Chem; 1996 Feb; 271(5):2868-73. PubMed ID: 8576268
[TBL] [Abstract][Full Text] [Related]
22. Long-chain fatty Acyl-CoA synthetase enzymatic activity in rat liver cell nuclei.
Ves-Losada A; Brenner RR
Mol Cell Biochem; 1996 Jun; 159(1):1-6. PubMed ID: 8813703
[TBL] [Abstract][Full Text] [Related]
23. Acyl-CoAs are functionally channeled in liver: potential role of acyl-CoA synthetase.
Muoio DM; Lewin TM; Wiedmer P; Coleman RA
Am J Physiol Endocrinol Metab; 2000 Dec; 279(6):E1366-73. PubMed ID: 11093925
[TBL] [Abstract][Full Text] [Related]
24. Long-chain acyl-coenzyme A synthetase from rat brain microsomes. Kinetic studies using [1-14C]docosahexaenoic acid substrate.
Reddy TS; Sprecher H; Bazan NG
Eur J Biochem; 1984 Nov; 145(1):21-9. PubMed ID: 6237910
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of RPE65 Retinol Isomerase Activity by Inhibitors of Lipid Metabolism.
Eroglu A; Gentleman S; Poliakov E; Redmond TM
J Biol Chem; 2016 Mar; 291(10):4966-73. PubMed ID: 26719343
[TBL] [Abstract][Full Text] [Related]
26. Downregulation of leptin by free fatty acids in rat adipocytes: effects of triacsin C, palmitate, and 2-bromopalmitate.
Shintani M; Nishimura H; Yonemitsu S; Masuzaki H; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Nakao K
Metabolism; 2000 Mar; 49(3):326-30. PubMed ID: 10726909
[TBL] [Abstract][Full Text] [Related]
27. Sepharose-stearate as substrate for rat liver long-chain fatty acyl-CoA synthetase.
Rosen G; Bar-Tana J
Biochim Biophys Acta; 1983 Feb; 743(1):121-8. PubMed ID: 6824695
[TBL] [Abstract][Full Text] [Related]
28. Subcellular distribution and characteristics of ciprofibroyl-CoA synthetase in rat liver. Its possible identity with long-chain acyl-CoA synthetase.
Amigo L; McElroy MC; Morales MN; Bronfman M
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):283-7. PubMed ID: 1599407
[TBL] [Abstract][Full Text] [Related]
29. Stable analogs of acyl adenylates. Inhibition of acetyl- and acyl-CoA synthetase by adenosine 5'-alkylphosphates.
Grayson NA; Westkaemper RB
Life Sci; 1988; 43(5):437-44. PubMed ID: 2899829
[TBL] [Abstract][Full Text] [Related]
30. Peroxisomal proliferators inhibit acyl CoA synthetase and stimulate protein kinase C in vivo.
Bojes HK; Thurman RG
Toxicol Appl Pharmacol; 1994 Jun; 126(2):233-9. PubMed ID: 8209376
[TBL] [Abstract][Full Text] [Related]
31. Biosynthesis of triacsin featuring an N-hydroxytriazene pharmacophore.
Del Rio Flores A; Twigg FF; Du Y; Cai W; Aguirre DQ; Sato M; Dror MJ; Narayanamoorthy M; Geng J; Zill NA; Zhai R; Zhang W
Nat Chem Biol; 2021 Dec; 17(12):1305-1313. PubMed ID: 34725510
[TBL] [Abstract][Full Text] [Related]
32. Fatty acid-induced beta cell hypersensitivity to glucose. Increased phosphofructokinase activity and lowered glucose-6-phosphate content.
Liu YQ; Tornheim K; Leahy JL
J Clin Invest; 1998 May; 101(9):1870-5. PubMed ID: 9576750
[TBL] [Abstract][Full Text] [Related]
33. Acyl-CoA synthetase activity of rat liver microsomes. Substrate specificity with special reference to very-long-chain and isomeric fatty acids.
Normann PT; Thomassen MS; Christiansen EN; Flatmark T
Biochim Biophys Acta; 1981 May; 664(2):416-27. PubMed ID: 7248332
[TBL] [Abstract][Full Text] [Related]
34. Long-chain acyl-CoA synthetase of rat testis microsomes. Substrate specificity and hormonal regulation.
Hurtado de Catalfo GE; de Gómez Dumm IN; Mandon EC
Biochem Mol Biol Int; 1993 Nov; 31(4):643-9. PubMed ID: 8298494
[TBL] [Abstract][Full Text] [Related]
35. Characterization of the Acyl-CoA synthetase activity of purified murine fatty acid transport protein 1.
Hall AM; Smith AJ; Bernlohr DA
J Biol Chem; 2003 Oct; 278(44):43008-13. PubMed ID: 12937175
[TBL] [Abstract][Full Text] [Related]
36. Evidence for a single non-arachidonic acid-specific fatty acyl-CoA synthetase in heart which is regulated by Mg2+.
Saunders C; Voigt JM; Weis MT
Biochem J; 1996 Feb; 313 ( Pt 3)(Pt 3):849-53. PubMed ID: 8611165
[TBL] [Abstract][Full Text] [Related]
37. Molecular specificity of a medium chain acyl-CoA synthetase for substrates and inhibitors: conformational analysis.
Kasuya F; Yamaoka Y; Igarashi K; Fukui M
Biochem Pharmacol; 1998 Jun; 55(11):1769-75. PubMed ID: 9714294
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of a medium chain acyl-CoA synthetase involved in glycine conjugation by carboxylic acids.
Kasuya F; Igarashi K; Fukui M
Biochem Pharmacol; 1996 Nov; 52(10):1643-6. PubMed ID: 8937481
[TBL] [Abstract][Full Text] [Related]
39. p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
Mashima T; Oh-hara T; Sato S; Mochizuki M; Sugimoto Y; Yamazaki K; Hamada J; Tada M; Moriuchi T; Ishikawa Y; Kato Y; Tomoda H; Yamori T; Tsuruo T
J Natl Cancer Inst; 2005 May; 97(10):765-77. PubMed ID: 15900046
[TBL] [Abstract][Full Text] [Related]
40. Acyl-CoA synthetase isoforms 1, 4, and 5 are present in different subcellular membranes in rat liver and can be inhibited independently.
Lewin TM; Kim JH; Granger DA; Vance JE; Coleman RA
J Biol Chem; 2001 Jul; 276(27):24674-9. PubMed ID: 11319232
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
